100
Participants
Start Date
July 11, 2023
Primary Completion Date
February 26, 2024
Study Completion Date
February 26, 2024
Control Group
Patients will be randomized to a 200mL (control group)
Test Group
Patients will be randomized to a cut-off of 150mL (test group)
Wake Forest University Health Sciences, Winston-Salem
Wake Forest University Health Sciences
OTHER